Breaking: AeroVironment, Transphorm, and Tesla - Market Movers
- June 27th, 2023
- 649 views
AeroVironment, Inc. (Nasdaq: AVAV) reported fourth-quarter fiscal 2023 adjusted EPS of $0.99, slightly below the consensus estimate of $1.01.
Looking ahead to the full-year fiscal 2024, the company anticipates revenue ranging between $630 million and $660 million, along with adjusted EPS between $2.30 and $2.60. This outlook exceeds the consensus estimate of $2.04 EPS on revenue of $600.24 million for the period.
In after-hours trading, $AVAV is currently priced at $95.30, reflecting a significant increase of $4.98 (5.51%).
Transphorm, Inc. (Nasdaq: TGAN) posted a loss of $0.13 per share for the fourth quarter of fiscal 2023, slightly worse than the consensus estimate of a loss of $0.11 per share.
The company also announced its intention to conduct a strategic review in the second quarter of fiscal 2024 to enhance shareholder value.
$TGAN is currently trading at $3.70 in after-hours, experiencing a decline of $0.03 (-0.80%).
In other news, Tesla, Inc. (Nasdaq: TSLA) has secured two new patents from The United States Patent and Trademark Office (USPTO), reinforcing its intellectual property protection.
The first patent, titled "Electronically controlled seat system with tilt-and-slide mode" (No. US 11,685,293 B2), and the second patent, titled "Method of making an electric drive unit having a gear shaft and rotor shaft with three bearings" (No. US 11,686,384 B2), showcase Tesla's continued innovation.
$TSLA is currently trading at $249.68, down $0.53 (0.21%) in after-hours.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login